Trial Profile
A phase I pilot study of ISA101 in combination with chemotherapy in patients with advanced cervical carcinoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 May 2014
Price :
$35
*
At a glance
- Drugs ISA 101 (Primary) ; Carboplatin; Paclitaxel
- Indications Cervical cancer; Human papillomavirus infections
- Focus Pharmacodynamics
- 29 May 2014 New trial record
- 07 Apr 2014 Summary of ISA101 programme as reported in the 105th Annual Meeting of the American Association for Cancer Research.